Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-073780
Filing Date
2025-08-04
Accepted
2025-08-04 20:45:58
Documents
2
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522414-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2522414-8_3seq1.xml 3 3562
2 EXHIBIT 24 tm2522414d8_ex24.htm EX-24 12160
  Complete submission text file 0001104659-25-073780.txt   17327
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
Langlois Sophia D. (Reporting) CIK: 0001903130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35803 | Film No.: 251182440